2nd International Conference on
Oncology and Cancer Research

Prof. Federico Biglioli, an eminent figure in the field of Maxillofacial Surgery, serves as the Chief of the Head and Neck Department and Maxillofacial Surgical Unit. Holding the prestigious position of Full Professor at Milan University, Italy, He is renowned for his expertise in complex surgical procedures and his contributions to advancing the field of maxillofacial surgery through research and education.

Oncology

Dr. Robert M. Brody, an accomplished Assistant Professor in Otorhinolaryngology Head and Neck Surgery, is affiliated with the University of Pennsylvania and the Veteran’s Administration Medical Center in Philadelphia, Pennsylvania. Known for his expertise in treating disorders of the head and neck, he is dedicated to education, research, and providing exceptional care to his patients.

Otorhinolaryngology and Oncology

Dr. Sat Parmar is a highly skilled Consultant Maxillofacial and Head and Neck Surgeon at the Maxillofacial Department of Queen Elizabeth Hospital, part of the University Hospitals Birmingham NHS Foundation Trust in Birmingham, United Kingdom. With a focus on excellence in surgical care, he is dedicated to advancing patient outcomes through innovative techniques and compassionate practice.

Cancer Research

Alessandro Pulsoni is at Sapienza University in Rome, Italy. He is highly rated in 10 conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Hairy Cell Leukemia, Follicular Lymphoma, and Non-Hodgkin Lymphoma. His clinical research consists of co-authoring 86 peer-reviewed articles and participating in 3 clinical trials in the past 15 years.

Oncology

Luca Roncati, MD-PhD, DMLS, is Associate Editor of the European Journal of Gynaecological Oncology (EJGO), Medical Executive at the University Hospital of Modena, and Adjunct Professor at the University of Modena and Reggio Emilia (Italy). Eponym of the Roncati-Manenti triad and describer of T rex lymphoma, he is the author of over 250 academic publications, he has taken part in the scientific work of various national and international research groups, he has organized several conferences of national relevance, he has attended as a speaker at numerous congresses and seminars, he holds the intellectual property of an Italian and international patent for anticancer therapy, and he has obtained various national and supranational awards.

Gynaecological Oncology; Gynaecological Pathology; Breast Cancer; Lymphoma; Human Papilloma Virus (HPV); HPV Test; PAP Smear

Dr. El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer / World Health Organization, (IARC/WHO), Lyon (France); He obtained a Master’s of Life and Health, Specialty Biology of microorganisms, Virology; a Master’s of Life and Health, option Immuno-physiopathology; a License of Biochemistry in Louis Pasteur University of Strasbourg (France); and a General Degree in Sciences and Technologies in University of METZ (France).

Cancer, Cancer incidence

Professor Safa received his Ph. D. in MCDB in 1980 from Iowa State University.In 1987, he accepted a position as an Assistant Professor of Medicine at the University of Chicago and was Director of the Laboratories of Pharmacology and Pharmacokinetics, and Molecular Pharmacology, respectively in the Section of Hematology/Oncology from 1990-1996. In 1996, he accepted a tenured Associate Professor Position in the Department of Experimental Oncology, Medical University of South Carolina (MUSC), and was promoted to tenured Professor in 1999. Dr. Safa was Director of the Drug Resistance Program at Hollings Cancer Center at MUSC from 1998-1999

His research interest includes multi-targeted therapy of pancreatic tumors, brain cancer, and breast cancer through modulation of the death receptor signaling pathway in cancer cells.

Mohammad Esmail Akbari is a Professor of Surgical Oncology at Shahid Beheshti University of Medical Sciences (SBUMS). He is the head of Cancer Research Center and comprehensive Cancer Control Center at SBUMS, a board member of EURAMA (Europa-Asian Breast Cancer Association), a member of Iranian and the American Association of Surgeons and the President of the Association of World with No Tobacco. He is the editor in chief of Iranian Cancer Prevention Journal. Furthermore he has been chancellor of Isfahan University of medical science and deputy for health in Ministry of Health and Medical Education (MOHME) for more than 12 years. He has published a considerable number of papers and books in the field of epidemiology of cancer and oncology

Oncology and Cancer

Board Certified in Plastic Surgery since 1999. Member of the American Society of Aesthetic Surgery and the American Society of Plastic Surgeons. Dr. Gregory Turowski is one of a few double board-certified plastic surgeons specializing in plastic and cosmetic face and body surgery. He combines a European background with knowledge and technical expertise that he acquired through years of surgical training at the most prestigious American Ivy League institutions: Yale and Harvard.

Reconstructive breast surgery for congenital breast anomalies, post-mastectomy breast cancer reconstruction, and breast reduction surgery

Michael Retsky (PhD in Physics from University of Chicago) made a career change to cancer research thirty years ago. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. Diagnosed with stage IIIc colon cancer in 1994, he opted for a low dose long term chemotherapy protocol that is now called metronomic chemotherapy. Retsky is Editor and Romano Demicheli is Co-Editor of a Springer/Nature book on breast cancer published in July 2017. Retsky is a founder of the Colon Cancer Alliance and has published more than 90 papers in physics and cancer.

Physics, Charged particle optics, Oncology